Marlborough-based medical device manufacturer Hologic has been issued a warning letter from the U.S. Food and Drug Administration concerning its BioZorb Marker, a device originally recalled in March.

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland (Reuters) - The U.S. health regulator on Tuesday warned patients and healthcare providers about the ...

A new study has demonstrated the safety and clinical effectiveness of a device Hologic is developing to aid with breast surgery. The study published in the Annals of Surgical Oncology, which Hologic ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics ...

On Friday, the FDA warned against using Hologic Inc.’s (NASDAQ:HOLX) BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the ...

ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading ...

HOLX's GYN Surgical unit gains momentum as the demand for gynecological devices rises globally, driven by innovation, M&A and strong overseas adoption.

Shares of Hologic HOLX closed the first trading session of the year at $74.56, which is quite close to the 52-week high of $75.34, reached on Dec. 15, 2025. In the past six months, the company has ...

A new private-label deal will see Hologic Inc. distributing a soft tissue biopsy instrument manufactured by Angiotech Pharmaceuticals Inc. Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) inked a three-year ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...